Filter Results:
(2,976)
Show Results For
- All HBS Web
(2,976)
- People (3)
- News (344)
- Research (2,335)
- Events (8)
- Multimedia (17)
- Faculty Publications (1,677)
Show Results For
- All HBS Web
(2,976)
- People (3)
- News (344)
- Research (2,335)
- Events (8)
- Multimedia (17)
- Faculty Publications (1,677)
- Article
Sizing Up Entrepreneurial Potential: Gender Differences in Communication and Investor Perceptions of Long-Term Growth and Scalability
By: Laura Huang, Priyanka D. Joshi, Cheryl J. Wakslak and Andy Wu
Female entrepreneurs have been found to face disadvantages as compared with male entrepreneurs, especially in acquiring the financial resources they need to sustain and grow their ventures. Across three studies, we examine how disparities in funding outcomes may be due... View Details
Huang, Laura, Priyanka D. Joshi, Cheryl J. Wakslak, and Andy Wu. "Sizing Up Entrepreneurial Potential: Gender Differences in Communication and Investor Perceptions of Long-Term Growth and Scalability." Academy of Management Journal 64, no. 3 (June 2021): 716–740.
- 2016
- Working Paper
Immigrant Entrepreneurship
By: Sari Pekkala Kerr and William R. Kerr
We examine immigrant entrepreneurship and the survival and growth of immigrant-founded businesses over time relative to native-founded companies. Our work quantifies immigrant contributions to new firm creation in a wide variety of fields using multiple definitions.... View Details
Keywords: Immigrants; Entrepreneurs; Entry; Firms; Growth; High-tech Marketing; Venture Capital; Entrepreneurship; Immigration; United States
Kerr, Sari Pekkala, and William R. Kerr. "Immigrant Entrepreneurship." Harvard Business School Working Paper, No. 17-011, July 2016. (NBER Working Paper Series, No. 22385, July 2016.)
- April 2014 (Revised July 2015)
- Case
Sanofi Pasteur: The Dengue Vaccine Dilemma
By: V. Kasturi Rangan, David E. Bloom, Vincent Dessain and Emilie Billaud
In 2012, Sanofi Pasteur was racing to develop a vaccine against dengue, a mosquito-borne disease, and was evaluating this product in a Phase IIb trial conducted with school children in Thailand. But while the candidate vaccine met the high safety expectations and a... View Details
Keywords: Health Testing and Trials; Product Launch; Market Entry and Exit; Emerging Markets; Pharmaceutical Industry; France
Rangan, V. Kasturi, David E. Bloom, Vincent Dessain, and Emilie Billaud. "Sanofi Pasteur: The Dengue Vaccine Dilemma." Harvard Business School Case 514-074, April 2014. (Revised July 2015.)
- 05 Sep 2023
- Book
Thriving After Failing: How to Turn Your Setbacks Into Triumphs
Harvard Business School Professor Amy Edmondson experienced her first big-stakes professional failure when she was just starting out in her academic career, some 30 years ago, after a decade working in engineering and consulting. Little did she know at the time, but... View Details
Keywords: by Michael Blanding
- 2020
- Working Paper
Determinants of Early-Stage Startup Performance: Survey Results
To explore determinants of new venture performance, the CEOs of 470 early-stage startups were surveyed regarding a broad range of factors related to their venture’s customer value proposition, product management, marketing, technology and operations, financial... View Details
Keywords: Startups; Survey Research; Performance Analysis; Entrepreneurship; Performance; Analysis; Business Startups; Failure; Surveys
Eisenmann, Thomas R. "Determinants of Early-Stage Startup Performance: Survey Results." Harvard Business School Working Paper, No. 21-057, October 2020.
- Article
'Matter Battles': Cognitive Representations, Boundary Objects, and the Failure of Collaboration in Two Smart Cities
By: Tiona Zuzul
In this paper, I present a longitudinal study of two smart city projects that brought together experts from diverse knowledge domains. Both projects structured collaboration around the development of boundary objects that could integrate actors’ expertise. In both... View Details
Zuzul, Tiona. "'Matter Battles': Cognitive Representations, Boundary Objects, and the Failure of Collaboration in Two Smart Cities." Academy of Management Journal 62, no. 3 (June 2019): 739–764.
- 23 May 2007
- Working Paper Summaries
What Causes Industry Agglomeration? Evidence from Coagglomeration Patterns
- September 2024
- Article
Gender Gaps: Back and Here to Stay? Evidence from Skilled Ugandan Workers During COVID-19
By: Livia Alfonsi, Mary Namubiru and Sara Spaziani
We investigate gender disparities in the effect of COVID-19 on the labor market outcomes of skilled Ugandan workers. Leveraging a high-frequency panel dataset, we find that the lockdowns imposed in Uganda reduced employment by 69% for women and by 45% for men,... View Details
Alfonsi, Livia, Mary Namubiru, and Sara Spaziani. "Gender Gaps: Back and Here to Stay? Evidence from Skilled Ugandan Workers During COVID-19." Review of Economics of the Household 22, no. 3 (September 2024): 999–1046.
- 02 Apr 2024
- What Do You Think?
What's Enough to Make Us Happy?
The result is measured in terms of outcomes that may be more or less than we expected, just as customer satisfaction is measured in terms of whether our expectations were met or exceeded. But how many of us take time out periodically to... View Details
Keywords: by James Heskett
- Research Summary
Integrated Care for Total Knee Replacement: Quality of Life, Quality of Movement, User Acceptability
This study provides an opportunity to focus on the challenge of cross-organizational coordination in the healthcare setting. It is structured as a randomized clinical trial involving seven European hospitals (in seven different countries). It is focused specifically... View Details
- September 2024
- Case
The Health Equity Accelerator at Boston Medical Center
By: Susanna Gallani, Mary Witkowski and Katie Sonnefeldt
This case describes how Boston Medical Center, a hospital and safety net organization, changed its strategic approach to health equity after realizing that previous efforts were not sufficient to address the health disparities among their patients. In 2021, the Health... View Details
Keywords: Health Care and Treatment; Health Disorders; Innovation and Management; Innovation Leadership; Innovation Strategy; Adaptation; Business Strategy; Mission and Purpose; Decisions; Organizational Change and Adaptation; Organizational Structure; Diversity; Race; Ethnicity; Urban Scope; Local Range; Equality and Inequality; Health Industry; Boston
Gallani, Susanna, Mary Witkowski, and Katie Sonnefeldt. "The Health Equity Accelerator at Boston Medical Center." Harvard Business School Case 125-039, September 2024.
- September 2017
- Case
Give Us a 'C'! Killing Knock-offs with Copyright?
By: Lena G. Goldberg
Varsity Brands, the leading manufacturer of cheerleading uniforms in the United States, obtained copyright protection for certain designs of stripes, chevrons, color blocks and lines on cheerleading uniforms. Star Athletica, a newcomer in the field, used those designs... View Details
Keywords: Intellectual Property; Law; Lawsuits and Litigation; Design; Apparel and Accessories Industry; Fashion Industry
Goldberg, Lena G. "Give Us a 'C'! Killing Knock-offs with Copyright?" Harvard Business School Case 318-046, September 2017.
- 2014
- Working Paper
Bio-Piracy or Prospering Together? Fuzzy Set and Qualitative Analysis of Herbal Patenting by Firms
By: Prithwiraj Choudhury and Tarun Khanna
Since the 1990s, several Western firms have filed patents based on medicinal herbs from emerging markets, evoking protests from local stakeholders against 'bio-piracy'. We explore conditions under which firms and local stakeholders share rents from such patents. Our... View Details
Keywords: Rents From New Technology; Local Stakeholders; Herbal Patents; QCA; Fuzzy Set Analysis; Qualitative Case Studies; Plant-Based Agribusiness; Patents; Emerging Markets; Health Care and Treatment; Business and Stakeholder Relations; Cross-Cultural and Cross-Border Issues; Agriculture and Agribusiness Industry; Pharmaceutical Industry
Choudhury, Prithwiraj, and Tarun Khanna. "Bio-Piracy or Prospering Together? Fuzzy Set and Qualitative Analysis of Herbal Patenting by Firms." Harvard Business School Working Paper, No. 14-081, February 2014.
- January 2011
- Case
The Risk-Reward Framework at Morgan Stanley Research
By: Suraj Srinivasan and David Lane
The case describes the Risk-Reward framework that Morgan Stanley analysts use as a systematic approach to communicate a broader range of fundamental insights about a company rather than the traditional single point estimates. The goal of the framework is to focus the... View Details
Keywords: Financial Statements; Forecasting and Prediction; Equity; Framework; Management Analysis, Tools, and Techniques; Risk Management; Business Processes; Research; Valuation
Srinivasan, Suraj, and David Lane. "The Risk-Reward Framework at Morgan Stanley Research." Harvard Business School Case 111-011, January 2011.
- 2010
- Working Paper
Agency Revisited
By: Ramon Casadesus-Masanell and Daniel F. Spulber
The article presents a comprehensive overview of the principal-agent model that emphasizes the role of trust in the agency relationship. The analysis demonstrates that the legal remedy for breach of duty can result in a full-information efficient outcome eliminating... View Details
Casadesus-Masanell, Ramon, and Daniel F. Spulber. "Agency Revisited." Harvard Business School Working Paper, No. 10-082, March 2010.
- 06 Jun 2024
- Research & Ideas
How Younger Immigrants Gain an Edge in American Business
you look across the many different experiences that countries are having with refugee and asylum-based migration, and the long run outcomes, even the older population in this setting is doing reasonably well,” Kerr says, adding there’s never one single factor to... View Details
Keywords: by Rachel Layne
- January 2024
- Article
Cost of Exempting Sole Orphan Drugs from Medicare Negotiation
By: Matthew Vogel, Olivia Zhao, William B. Feldman, Amitabh Chandra, Aaron S. Kesselheim and Benjamin N. Rome
Importance: The Inflation Reduction Act (IRA) requires Medicare to negotiate prices for some high-spending drugs but exempts drugs approved solely for the treatment of a single rare disease.
Objective: To estimate Medicare spending and global... View Details
Objective: To estimate Medicare spending and global... View Details
Vogel, Matthew, Olivia Zhao, William B. Feldman, Amitabh Chandra, Aaron S. Kesselheim, and Benjamin N. Rome. "Cost of Exempting Sole Orphan Drugs from Medicare Negotiation." JAMA Internal Medicine 184, no. 1 (January 2024): 63–69.
- Program
PLD Module 5
strategic decisions with a deeper understanding of the financial implications Help your company deliver greater value to a wide range of stakeholders Navigate high-stakes negotiations and drive better outcomes Expand your personal and... View Details
- Research Summary
Markets, Information, and Efficiency
Professor Meulbroeks market efficiency research focuses on the closely related questions of whether markets properly reflect information that affects a firm's value, and in turn how stock prices influence managerial behavior. In this area, she studies why some firms... View Details
- 2024
- Chapter
What Future for the Renminbi in the Global Monetary System?
By: Edoardo Campanella and Meg Rithmire
What is a realistic and positive outcome for US-China relations in the realm of global finance over the next ten years? While some policymakers, especially in the US, have feared that China holds ambitions for the renminbi (RMB) to replace the dollar as a global... View Details
Keywords: International Relations; Currency; Macroeconomics; Globalized Economies and Regions; China; United States
Campanella, Edoardo, and Meg Rithmire. "What Future for the Renminbi in the Global Monetary System?" Chap. 7 in U.S.-China Relations for the 2030s: Toward a Realistic Scenario for Coexistence, edited by Chris Chivvis, C. Fred Bergsten, Edoardo Campanella, John Culver, Rosemary Foot, M. Taylor Fravel, Eric Heginbotham, Evan S. Medeiros, Meg Rithmire, George Perkovich, Stephen M. Walt, Stephen Wertheim, and Audrye Wong, 67–78. Washington D.C.: Carnegie Endowment for International Peace, 2024.